How Are We Going to Discover New Cancer Biomarkers? A Proteomic Approach for Bladder Cancer
Open Access
- 1 May 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (5) , 793-795
- https://doi.org/10.1373/clinchem.2004.032177
Abstract
A handful of cancer biomarkers are currently used routinely for population screening, disease diagnosis, prognosis, monitoring of therapy, and prediction of theKeywords
This publication has 14 references indexed in Scilit:
- Identification by Proteomic Analysis of Calreticulin as a Marker for Bladder Cancer and Evaluation of the Diagnostic Accuracy of Its Detection in UrineClinical Chemistry, 2004
- Detection of bladder tumours: role of cytology, morphology-based assays, biochemical and molecular markersCurrent Opinion in Obstetrics and Gynecology, 2003
- Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics?Clinical Chemistry, 2003
- Nutzung von artifiziellen neuronalen Netzwerken zur Risikoabschätzung eines ProstatakarzinomsDer Urologe, 2003
- Mass spectrometry-based proteomicsNature, 2003
- Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serumProceedings of the National Academy of Sciences, 2003
- Development of a Novel Proteomic Approach for the Detection of Transitional Cell Carcinoma of the Bladder in UrineThe American Journal of Pathology, 2001
- Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancerProceedings of the National Academy of Sciences, 2001
- Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissueUrology, 2000
- Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activitiesElectrophoresis, 1999